By: Zachary Brennan
The Institute for Clinical and Economic Review on Thursday released a new report arguing that US healthcare costs rose by more than $800 million from …
Zachary Brennan is a Senior Editor at Cureus Journal of Medical Science and Endpoints News. He specializes in medicine and healthcare, focusing on topics such as FDA regulations, alternative medicine, and healthcare technology, while also covering significant issues like the Coronavirus pandemic and inflation in the healthcare sector. Zachary's insights and analyses have been featured in prominent publications, including Cureus Journal of Medical Science and Endpoints News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Zachary Brennan's coverage overwhelmingly focuses on healthcare and pharmaceuticals, particularly around government announcements and legal policy regulations. He seems most interested in covering stories related to the FDA, drug approval processes, drug pricing, pharmaceutical companies, and clinical trials.
Given this focus, Zachary would likely be highly receptive to pitches from experts within the healthcare industry who can provide insights into regulatory changes impacting drug approvals or pricing. Additionally, professionals with expertise in clinical trials oversight or experience navigating FDA processes may find success reaching out to him for commentary.
As his geographic focus is not specified but given the nature of his reporting which heavily involves U.S. government agencies such as the FDA and specific U.S.-related policies like drug price regulation laws; it is fair to assume he has a U.S.-centric perspective.
This information evolves through artificial intelligence and human feedback. Improve this profile .